The Surge in Biotech Investment for Women's Health The "FemTech" revolution has reached a fever pitch in 2026, with endometriosis treatment standing at the forefront of this movement. Venture capital firms that previously overlooked women's health are now pouring resources into startups developing novel anti-inflammatory and non-hormonal drugs. This influx of capital is accelerating clinical...